Clinical trial
Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
NCT06495008 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy
- Lead sponsor
- University Medical Center Groningen
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 26, 2023
- Completion date
- February 11, 2025
- Enrollment
- 101 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma, non-small cell lung cancer (nsclc), urogenital cancers